Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Latta

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cells|May 13, 2023
Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic ChangesJan Boeckhaus, Lea Mohr, Hassan Dihazi, et al.
Kidney International Reports|May 7, 2026
German Clinical Practice Guideline on Microhematuria in Children and Young Adults: Evaluating Early Detection of Kidney DiseaseKay Latta, Jan Boeckhaus, Ina Weinreich, et al.
Frontiers in Pediatrics|May 9, 2022
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and AustriaKristina Vollbach, Catharina Schuetz, Christian M Hedrich, et al.
Kidney International|April 18, 2020
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndromeOliver Gross, Burkhard Tönshoff, Lutz T Weber, et al.
Clinical Genetics|October 11, 2020
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trialJan Boeckhaus, Julia Hoefele, Korbinian M Riedhammer, et al.
Pediatric Nephrology (Berlin, Germany)|February 4, 2025
Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndromeJan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, et al.
Kidney International Reports|July 13, 2026
Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular SyndromeFrancesco Emma, Detlef Böckenhauer, Andrew J Mallett, et al.
Transplantation|November 14, 2008
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroidsGisela Offner, Burkhard Toenshoff, Britta Höcker, et al.
The Journal of Clinical Investigation|June 1, 2022
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal functionMathilda Bedin, Olivia Boyer, Aude Servais, et al.
The Journal of Clinical Investigation|October 16, 2019
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal functionMathilda Bedin, Olivia Boyer, Aude Servais, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cells|May 13, 2023
Ratio of Urinary Proteins to Albumin Excretion Shifts Substantially during Progression of the Podocytopathy Alport Syndrome, and Spot Urine Is a Reliable Method to Detect These Pathologic ChangesJan Boeckhaus, Lea Mohr, Hassan Dihazi, et al.
Kidney International Reports|May 7, 2026
German Clinical Practice Guideline on Microhematuria in Children and Young Adults: Evaluating Early Detection of Kidney DiseaseKay Latta, Jan Boeckhaus, Ina Weinreich, et al.
Frontiers in Pediatrics|May 9, 2022
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and AustriaKristina Vollbach, Catharina Schuetz, Christian M Hedrich, et al.
Kidney International|April 18, 2020
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndromeOliver Gross, Burkhard Tönshoff, Lutz T Weber, et al.
Clinical Genetics|October 11, 2020
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trialJan Boeckhaus, Julia Hoefele, Korbinian M Riedhammer, et al.
Pediatric Nephrology (Berlin, Germany)|February 4, 2025
Urinary Dickkopf-related protein 3 as a novel biomarker for kidney function decline in children with Alport syndromeJan Boeckhaus, Burkhard Tönshoff, Lutz T Weber, et al.
Kidney International Reports|July 13, 2026
Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular SyndromeFrancesco Emma, Detlef Böckenhauer, Andrew J Mallett, et al.
Transplantation|November 14, 2008
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroidsGisela Offner, Burkhard Toenshoff, Britta Höcker, et al.
The Journal of Clinical Investigation|June 1, 2022
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal functionMathilda Bedin, Olivia Boyer, Aude Servais, et al.
The Journal of Clinical Investigation|October 16, 2019
Human C-terminal CUBN variants associate with chronic proteinuria and normal renal functionMathilda Bedin, Olivia Boyer, Aude Servais, et al.
Pageof 3